A population-based case-control study was conducted between 1988 and 1995 in the San Francisco Bay Area of California to determine risk factors for non-Hodgkin's lymphoma. Participants completed in-person interviews, and Wood was drawn to test for viruses and lymphocyte subsets. This report includes data for 1,281 cases and 2,095 controls. In multivariate analyses, the factors associated with a decreased risk for nonHodgkin's lymphoma were allergy to plants, bee and wasp stings, five or more vaccinations, drugs to lower blood cholesterol, nonsteroidal anti-inflammatory drugs, total number of sexual partners, and lifetime marijuana use, whereas an increased risk was associated with cimetidine and other histamine H 2 -receptor antagonists, splenectomy, gonorrhea, and body mass index. Unique to sex-specific models was an increased risk for endocrine gland disorders among women and for polio among men. Median CD3, CD4, CD8, CD20, and lymphocyte counts for non-Hodgkin's lymphoma patients were significantly lower than those for controls. These results implicate environmental factors that may influence the early stages of lymphomagenesis by stimulating the immune system. Antigen-driven B cells that accumulate to form lymphoma may be suppressed by immunologic stresses such as exposure to an increased number of sexual partners and to certain medications. A history of allergies provides evidence for a persistent capacity for B-cell differentiation and therefore a decreased accumulation of B cells. The decreased risk for non-Hodgkin's lymphoma with use of nonsteroidal anti-inflammatory drugs and cholesterol-lowering drugs is consistent with a macrophage inflammatory role in Bcell proliferation. Am J Epidemiol 1999; 150:375-89.
The annual percentage increase in non-Hodgkin's lymphoraa of nearly 4 percent among men and 3 percent among women has exceeded the increases for all other cancers except melanoma of the skin, lung cancer among women (1, 2) , and prostate cancer (1) , which has been highly influenced by prostate-specific antigen testing. Despite this increased incidence, few risk factors for non-Hodgkin's lymphoma are known, and they do not explain the emerging epidemic (2, 3) . Increased chronologic age, immunodeficiency, genetic susceptibility, antigenic stimulation, and chromosomal rearrangement are pathogenic factors that have been found to be asso-ciated with the process of lymphomagenesis (4) . The individual and interactive effects of these factors and their role in the etiology of non-Hodgkin's lymphoma are complex and poorly defined. However, methodological advances in DNA and genetic testing, combined with evidence from clinical and epidemiologic studies, have helped to elucidate some of these processes.
Persons infected with the human immunodeficiency virus (HTV) are at increased risk for the development of high-grade non-Hodgkin's lymphoma (5) . Because of the difference in incidence and related risk factors, the homosexual men who were included in our investigation were studied separately; results for these subjects have been published previously (6, 7) . Our results regarding both HIV-positive and HTV-negative homosexual men showed a decreased risk for nonHodgkin's lymphoma associated with an increased frequency of receptive anal intercourse and a history of allergies (6) . HIV-positive homosexual men also had decreased risks associated with bee and wasp stings, a history of influenza vaccination, and a greater lifetime frequency of use of amphetamines (6) .
This large, population-based case-control study was designed to investigate a priori hypotheses based on Controls were identified by using random digit dialing (23, 24) and were frequency-matched to patients by sex, county of residence, and age within 5 years. Details of the random digit dialing procedure used to identify controls have been reported previously (6) . A total of 2,515 (78 percent) eligible controls completed interviews; of these, 838 women and 1,257 heterosexual men formed the control group for the present report. The remaining 420 controls were homosexual men included in the first reports on HTV-related lymphomas (6, 7) . Among the controls, no women and one heterosexual man were HIV-positive.
Interviews
Structured, face-to-face interviews were conducted by trained interviewers in study subjects' homes or at places convenient to the subjects. Interview topics covered family and personal medical history and included details about common allergies, medical procedures and conditions such as autoimmune diseases, use of therapeutic drugs for at least 4 consecutive weeks, history of immunizations and viral infections, sexual history, use of tobacco and illicit drugs and consumption of alcohol, demographic characteristics, and family income. Detailed questions also were asked about exposures to chemicals during work, school, or leisure activities; job history; and travel to foreign countries. Most questions pertained to exposures or activities that excluded the year prior to the interview. No proxy interviews were conducted.
Laboratory specimens
Bloods were drawn from consenting participants who had no history of chemotherapy within the past 3 months. The specimens were analyzed for HIV and for human T-lymphotrophic virus (HTLV)-I and -II. Analyses for CD3, CD4, CD8, CD20, lymphocyte, and white blood cell counts were performed on blood drawn from participants who had not received chemotherapy. HTV and HTLV-I serologic testing was conducted by using enzyme-linked immunosorbent assay and Western blot assay (Diagnostic Biotech, Singapore). HTLV-II serology was performed on HTLV-I indeterminate specimens.
Statistical analysis
Unconditional logistic regression was used to obtain odds ratios as estimates of the relative risks for all factors. Odds ratios were first adjusted for age alone and later for potential confounders in multivariate models. Also computed were 95 percent confidence intervals for the odds ratios and associated two-tailed p values. In this report, effects are referred to as borderline when the p value is between 0.05 and 0.10. All possible associations, as well as interactions between predictors, were assessed.
All analyses were first stratified by sex. This report presents age-adjusted results separately when sexspecific odds ratios varied by more than 10 percent from the combined results and together when individual odds ratios were similar but small numbers of exposed participants precluded presenting meaningful results by sex. Multivariate models that considered the biology of the disease were fit separately by sex and for women and men combined. The small proportion (<1 percent) of HIV-positive heterosexual patients included in the analyses presented here had no effect on the risk estimates.
Age was categorized into nine groups for univariate analyses and as <55 or >55 years for the multivariate models. Other noncategorical covariates were considered binary, tertiles, or quartiles by using all controls, unless a paucity of measurements or the meaning of categories forced a slightly different classification. Medical conditions that occurred more than 5 years prior to the date of the interview were used in the analyses to avoid spurious associations with diseases diagnosed as a result of the onset of non-Hodgkin's lymphoma. Weight and height were considered together as body mass index (weight in kg/height in m 2 ) and were grouped for analyses as <20 (lean), 20-<25 (normal range), 25-<30 (class 1 overweight), and i>30 (class 2 and class 3 overweight) (25) .
Alcohol consumption data were collected as the number of drinks consumed per week of beer, wine, or liquor (one 12 oz can was defined as one drink of beer, one 4 oz glass as one drink of wine, and 1 oz of liquor as one drink of liquor; 1 oz = 30 ml) during the specific age intervals of 15-19, 20-29, 30-39, 40-49, 50-59, and years. Total consumption for each person was calculated separately for beer, wine, and liquor by multiplying the number of drinks consumed by the number of years in each age interval and adding across intervals.
Participants who reported illicit use of a drug were asked to provide their age when the drug was first and last used and to specify their lifetime frequency of use as one of 12 categories. Data on the lifetime number of sexual partners also were collected as a categorical variable. Participants were asked to select one of 22 categories that best described their total number of sexual partners up to 1 year prior to the interview.
Many results from the age-adjusted analyses are presented in the text and tables of this report if they were found in previous studies or were of a priori interest. Age-adjusted results that were dissimilar in men and women or were based on small numbers are presented in the text only. However, most age-adjusted results are shown only in the tables. Factors found to be associated with non-Hodgkin's lymphoma when the multivariate analyses were conducted are discussed in the Multivariate Analysis portion and are omitted from the Age-adjusted Analyses portion of the Results section.
RESULTS

Age-adjusted analyses
Demographics and foreign travel. The distributions of demographic factors for non-Hodgkin's lymphoma cases and controls, by sex, are presented in table 1. The median ages of women with non-Hodgkin's lymphoma ) on the basis of women's weight at age 25 years and men's usual adult weight. § Half-brothers and half-sisters were included. H One drink was defined as 12 oz of beer, 4 oz of wine, or 1 oz of liquor; 1 oz = 30 ml. Cutpoints for lifetime average number of drinks/week were based on tertiles of the distribution among controls-women: low, £2.2; medium, >2.2-<5.8; high, £5.8; men: low, £5.5; medium, >5.5-<13.6; high £13.6. and of their controls were 61.5 and 61 years, respectively. The respective median ages of heterosexual men were 58 and 53 years. Controls were slightly more educated than cases. These slight variations were not apparent when odds ratios were computed. Distributions also were similar between non-Hodgkin's lymphoma cases and controls by family income, race, and religion as a child (data for religion not shown).
Age-adjusted analyses showed a modest trend with an increased risk for non-Hodgkin's lymphoma associated with having an increasing number of siblings (table 2) . Among women, being divorced (odds ratio (OR) = 0.51, 95 percent confidence interval (CI): 0.38, 0.68) or never having married (OR = 0.67, 95 percent CI: 0.46, 0.99) was associated with a decreased risk for nonHodgkin's lymphoma compared with women who were married at the time of the interview (data not shown). Risk for non-Hodgkin's lymphoma was not associated with foreign travel or with contact with persons returning from Africa (data not shown).
Tobacco and illicit drug use and alcohol consumption. Ever having smoked cigarettes was not associated with risk for non-Hodgkin's lymphoma (table 2) . Compared with participants who had no history of having regularly consumed at least one drink per month, consumers of alcohol had a slightly reduced risk for non-Hodgkin's lymphoma, particularly women (table  2) . Individual results for beer, wine, and liquor showed somewhat similar effects (data not shown).
For men who used some illicit drugs, there was a trend toward a reduced risk for non-Hodgkin's lymphoma with increased frequency of substance use, whereas results were less consistent for women (table  2) . Among men, a reduced risk also was associated with ever use of magic mushrooms or psilocybin (OR = 0.47, 95 percent CI: 0.24, 0.95) compared with never use of these substances. Intravenous drug use among HTVnegative subjects was analyzed by pooling over sex because of the small number of women who reported ever having injected drugs. Risk for non-Hodgkin's lymphoma was not associated with intravenous streetdrug use regardless of whether needles were shared (ever shared needles, OR = 1.3,95 percent CI: 0.58,2.8; never shared needles, OR = 0.94, 95 percent CI: 0.29, 3.2). However, among HTV-negative subjects, analyses by specific drugs showed that ever having injected speed, methamphetamine, or other amphetamines was associated with a 5.7-fold increased risk for nonHodgkin's lymphoma for women and men combined (95 percent CI: 1.8, 18; 10 non-Hodgkin's lymphoma patients exposed, 4 controls exposed).
Allergies. Among both the non-Hodgkin's lymphoma cases and the controls, a greater proportion of women than men reported having had allergies (table   3) . Women and men who received regular injections to treat allergies and asthma also showed decreased risks for non-Hodgkin's lymphoma. Among women, significantly decreased risks were associated with allergies to medications, food, and dust, chalk, or mold and with a history of hives, whereas allergies to animals were associated with a decreased risk for non-Hodgkin's lymphoma among men.
Vaccinations and medications. Among women and men, a reduced risk for non-Hodgkin's lymphoma was associated with adult vaccination against several diseases and with an increase in the lifetime number of different types of vaccinations (table 3) , and polio, whereas there were no significant associations with childhood vaccinations among women (data not shown). Men who had non-Hodgkin's lymphoma were less likely to have been vaccinated against polio before age 10 years, but there was no association among women (table 3) .
Subjects also were asked about their use of therapeutic medications for at least 4 consecutive weeks prior to 1 year before the interview (controls) or prior to 1 year before diagnosis (cases) (table 3). A reduced risk for non-Hodgkin's lymphoma was associated with use of diazepam among men (OR = 0.54, 95 percent CI: 0.33, 0.90). Among women and men, no risk for non-Hodgkin's lymphoma was associated with use of antibiotics, acetaminophen, medications for hypertension, steroids, or barbiturates; phenytoin sodium, allopurinol, insulin, or other drugs to control diabetes; or drugs to control weight.
Other health conditions and medical procedures. Among women, a reduced risk for nonHodgkin's lymphoma was associated with a history of rubella (OR = 0.76, 95 percent CI: 0.60, 0.96), whooping cough (OR = 0.76, 95 percent CI: 0.60, 0.98), cold sores or fever blisters (OR = 0.78, 95 percent CI: 0.62, 0.98), canker sores (OR = 0.69, 95 percent CI: 0.55, 0.86), and tooth abscess (OR = 0.74,95 percent CI: 0.58, 0.94). There was no further evidence of risk associated with a history of most other childhood and adult infectious and chronic disorders, including mononucleosis, sexually transmitted diseases other than gonorrhea, nonrheumatoid arthritis, autoimmune diseases, diabetes, heart disease, and diseases of other major organs (data not shown). A history of medical procedures such as diagnostic radiographic examinations, blood transfusions, appendectomy, tonsillectomy, or organ transplant (two non-Hodgkin's lymphoma patients reported kidney transplants) also was not associated with risk for nonHodgkin's lymphoma (data not shown).
Family history of hematopoietic cancer. A reported history of lymphoma, leukemia, or Hodgkin's disease in a parent, child, or sibling was associated with an elevated risk for non-Hodgkin's lymphoma among women (OR = 1.7, 95 percent CI: 1.1, 2.7), with a borderline result among men (OR =
Multlvariate analysis
All models were adjusted for age and education; the combined model also was adjusted for sex (table 4) . Each of the three models showed an independent risk for non-Hodgkin's lymphoma associated with allergy to grass, hay, trees, leaves, other plants, and pollen; three or more bee and wasp stings; five or more different types of vaccinations; use of nonsteroidal antiinflammatory drugs (NSATDs) (aspirin, enteric-coated aspirin, ibuprofen, naproxen, naproxen sodium, diflunisal, sulindac, indomethacin, salsalate, piroxicam, tolmetin sodium, diclofenac sodium, phenylbutazone, and ketoprofen); use of cholesterol-lowering drugs; use of cimetidine and other histamine Hj-receptor antagonists (ranitidine, famotidine, and nizatidine) to treat ulcers; body mass index score; and lifetime number of sexual partners. Most of these exposures were related to decreased risks for non-Hodgkin's lymphoma, with the exceptions of an increased risk related to an increased body mass index score and to the use of cimetidine and other histamine Hj-receptor antagonists.
In addition, in the individual models, women who reported non-thyroid-related endocrine gland disorders (pituitary, estrogen or other female hormone, adrenal, parathyroid, and hyperinsulinemia) had a 3.3-fold increased risk for non-Hodgkin's lymphoma, whereas men who had been diagnosed with polio had a 2.6-fold increased risk. The men's model and the combined model showed similar elevated risks for nonHodgkin's lymphoma related to a history of gonorrhea and similar decreased risks associated with an increased lifetime frequency of marijuana use. An increased risk for non-Hodgkin's lymphoma associated with a history of splenectomy was significant only in the combined model, although sex-specific, ageadjusted risks were of similar magnitude.
Laboratory results
A total of 62 percent of eligible non-Hodgkin's lymphoma patients and 62 percent of controls signed separate consent forms to have their blood drawn. Values for each blood parameter were similar for women and men, and data were combined for analyses. The median CD3, CD4, CD8, CD20, and lymphocyte counts for non-Hodgkin's lymphoma patients were significantly lower than those for controls (table 5) . One control and no non-Hodgkin's lymphoma patients were seropositive for HTLV-I, and no participants were seropositive for HTLV-II.
DISCUSSION
Epidemiologic significance
Risk factors for non-Hodgkin's lymphoma from the final multivariate models can be categorized into three broad groups of exposures related to the function and integrity of the immune system: use of medications, lifestyle factors, and medical history, including allergies and immunizations. After control for potential confounders, history of plant allergies, number of bee and wasp stings, number of different types of vaccinations, use of NSATDs, use of cholesterol-lowering drugs, and lifetime number of sexual partners were independently associated with a decreased risk for non-Hodgkin's lymphoma among women and men. Increasing body mass index score, history of splenectomy, and use of cimetidine and other histamine Hj-receptor antagonists to treat ulcers were associated with an increased risk for nonHodgkin's lymphoma. In addition, increased risks were found among women with non-thyroid-related endocrine gland disorders and among men who had a history of polio and gonorrhea. Risk for non-Hodgkin's lymphoma decreased with increased frequency of marijuana use among men but not among women.
A priori hypotheses about risk factors that affect immune system function, such as common allergies, bee and wasp stings, and immunizations, were based on etiologic clues from previous studies (5, 8-10, 12-17, 26) and were confirmed in the age-adjusted and multivariate analyses, both in the earlier analyses of homosexual men (6) and in the present analyses of women and heterosexual men. Studies of other cancers have reported reduced risks associated with allergy-related conditions (27) (28) (29) (30) (31) (32) , whereas for non-Hodgkin's lymphoma, results from earlier investigations have varied (6, 11, (33) (34) (35) . Our results were consistent with earlier work, which found that women reported more allergies than men and that a decreased risk for cancer was associated with a history of allergy-related manifestations (30, 32) . A reduced risk for non-Hodgkin's lymphoma * The number of subjects may vary among factors because of missing values. t Adjusted for age. $ Conditions that occurred more than 5 years before the diagnosis or interview date. § Includes tetanus vaccine, diphtheria-pertussis-tetanus vaccine, and tetanus shots after injury. ) on the basis of women's weight at age 25 years and men's usual adult weight. H Women, 2-4 and men, 2-14; women, £5 and men, £15. # The risk associated with gonorrhea was found only in men. • Lymphocyte subsets were performed only for patients who did not receive chemotherapy, t Difference between median value for cases and controls.
associated with reaction to insect stings also supports earlier results (33) . A possible explanation for our specific findings for allergies and for bee and wasp stings is related to people's responses to allergens and insect venom. Insect venom, particularly that of bees and wasps, initiates an inflammatory response that triggers cytokines to release histamine (36, 37) . Histamine also is secreted in response to allergen exposures in atopic persons. Blood and tissue levels of histamine have been directly related to natural killer cell activity and have been inversely correlated with the presence of malignant tumors (38) . In addition, the role of allergies in non-Hodgkin's lymphoma may be related to the unique ability of persons with a history of allergies to mount an immune response that requires B cells to switch immunoglobulin expression from immunoglobulin M through to immunoglobulin E.
Among women and men, the observed association with lifetime number of sexual partners was similar to the results reported in our study of non-Hodgkin's lymphoma among homosexual men (6) . Seminal fluid is antigenic; in human and in animal studies, it has been shown to inhibit lymphocyte activation (39) (40) (41) . Semen also is mildly immunosuppressive, and failure of its immunosuppressive activity results in the production of antibodies to semen (39) (40) (41) . In men, development of serum antibodies to semen can result from exposure to their own seminal fluid because of reproductive tract trauma, infection with a sexually transmitted disease, or vasectomy (42) . Divorced or nevermarried women had a decreased risk for nonHodgkin's lymphoma and were more likely to have had more sexual partners, with greater exposure to the immunosuppressive effects of seminal fluid.
In the multivariate model, a reduced risk for nonHodgkin's lymphoma was found for both women and men who had received five or more different types of vaccinations during their lifetime. We no longer observed the age-adjusted associations between risk for non-Hodgkin's lymphoma and younger age at polio vaccination among men, an effect that had remained after adjustment for several factors for HTV-negative homosexual men in our earlier report (6) . Vaccines and their effects on the immune system vary, and the biologic mechanism of immune stimulation prompted by individual vaccines may be pertinent to the development of non-Hodgkin's lymphoma.
In this investigation, we tested a priori hypotheses regarding use of medications for 4 consecutive weeks or longer. In the multivariate models, a decreased risk for non-Hodgkin's lymphoma was associated with use of cholesterol-lowering drugs and use of NSATDs (including aspirin). Initiation of an immune response requires macrophage activation and production of inflammatory mediators (43) . A decreased risk for non-Hodgkin's lymphoma associated with NSAID use suggests an active role for macrophage-mediated inflammation. NSAIDs block macrophage production of B-cell growth factors, and animal models have shown that activated macrophages contribute to lymphomagenesis (43) . A reduced risk for non-Hodgkin's lymphoma associated with use of pain relievers has been reported (33) , and indomethacin has inhibited plasmacytoma development in mice (44) . Evidence for the use of NSAIDs in reducing the risk for cancer also has come from studies of colorectal cancer (45) . Similar to NSAIDs, cholesterollowering drugs also may decrease macrophage activation indirectly by decreasing the amount of cholesterol, a substance known to activate macrophages.
In contrast, we found that the use of cimetidine and other histamine H^receptor antagonists was associated with an increased risk for non-Hodgkin's lymphoma. The relation between non-Hodgkin's lymphoma and the use of drugs to treat ulcers is supportive of studies that have suggested a link between cancer and use of cimetidine or histamine Hj-receptor antagonists to treat ulcers (46, 47) . Because the association was found among only those persons who had received cimetidine and other histamine IL-receptor antagonists, it may be that these study participants had Helicobacter pylorirelated ulcers known to be difficult to treat with standard ulcer therapies. We did not ask about infection with H. pylori, but current research indicates that it is the main cause of chronic gastritis and is associated with peptic ulcer disease, gastric cancer (48), and gastric mucosa-associated lymphoid tissue lymphoma (48, 49) . H. pylori treatment and eradication often results in the regression of mucosa-associated lymphoid tissue lymphoma (49, 50) , and regression or inhibition of tumor growth in gastric cancer has been achieved with the use of some histamine Hj-receptor antagonists (46) .
Regarding lifetime frequency of use among men, marijuana was the only recreational drug that remained associated with a reduced risk for non-Hodgkin's lymphoma after adjustment for potential confounding factors. Previous results examining the association between non-Hodgkin's lymphoma and recreational drug use (51) or alcohol consumption have reported no relation (51, 52) . However, others have shown an increased risk among men who used recreational drugs and a decreased risk with increased consumption of alcohol among women, although confounding factors could not be excluded (53) . An increased risk for nonHodgkin's lymphoma among drinkers of beer and "mate" also has been reported (54) . The use of some recreational drugs causes mild immunosuppression (55, 56) , but their role in the etiology of nonHodgkin's lymphoma is uncertain based on inconsistent results and our finding of few dose-related trends.
The relation between body mass index and risk for non-Hodgkin's lymphoma has been reported inconsistently. Similar to our results, an earlier cohort study found an increased risk with higher ponderal index (57), whereas a hospital-based study conducted in Italy found no association between body mass index and non-Hodgkin's lymphoma (58) . Further investigations are needed to elucidate the significance of body mass index in the risk for non-Hodgkin's lymphoma.
Reports of the relation between common childhood and adult illnesses and non-Hodgkin's lymphoma have been inconsistent. A history of eczema (11, 33) , scarlet fever (11, 35) , varicella (57), herpes zoster (11, 35) , pyelonephritis (35) , pneumonia (11) , and infectious mononucleosis (11) has been related to non-Hodgkin's lymphoma, but our results did not support these findings. Previous investigations also reported an increased risk for non-Hodgkin's lymphoma associated with diabetes mellitus (11, 59) , history of blood transfusions (60, 61) , organ transplants (62, 63) , and autoimmune disorders such as Sjogren's syndrome (64) and rheumatoid arthritis (65) , whereas risk estimates associated with a history of tonsillectomy and appendectomy have been inconsistent (35, 57, 66) . We found no associations between risk for non-Hodgkin's lymphoma and any of these medical conditions. An elevated risk associated with polio in men was reported as borderline significant by another study (33) . Endocrine gland disorders and splenectomy are likely to be related to overall immune system function. Splenectomy for nontraumatic reasons such as chronic platelet disorders and hemolytic anemias indicates immune system malfunction that may place these persons at greater risk for non-Hodgkin's lymphoma. However, we had no detailed information regarding splenectomy.
Lymphocyte subset analysis was performed on all blood specimens obtained from participants who had no history of recent chemotherapy. Non-Hodgkin's lymphoma patients were significantly lymphopenic, with all T-and B-cell subsets markedly decreased compared with controls. This type of shift in white blood cell count also has been observed in persons with HTV infection. The lower CD4/CD8 ratio found among the non-Hodgkin's lymphoma participants is typical of acute and chronic viral infections.
Potential for bias
We obtained our non-Hodgkin's lymphoma patients by using a rapid case ascertainment system. We used random digit dialing to obtain controls and frequencymatched them to the patients to diminish the potential effects of selection and participation biases and to increase the generalizability of results. The use of a standardized questionnaire administered in person by trained interviewers was implemented to reduce response biases.
Other potential problems such as recall bias, chance, and confounding can be inherent in this type of research, despite use of this design. The potential for recall bias may be problematic, especially when participants are asked to report events that occurred many years prior to interview or that require accurate placement of an event within a narrow time period. However, it is unlikely that cases and controls would differentially recall past exposures not perceived to be related to the disease. These forms of bias in the data are more problematic than the potential for investigators to report results due to chance (67) . Response bias also can occur with the reporting of sensitive information such as sexual behavior and drug use. Drug exposures may be underreported especially by infrequent users (68, 69) . In addition, inconsistencies in reported drug use may be substance dependent and influenced by increasing age (68, 69) . Few subjects in our study refused to respond to personal questions, and interviewers were highly confident of the reliability of the responses.
Study size was calculated to ensure sufficient statistical power to test a priori hypotheses, and results often were consistent with data from earlier investigations. Results based on small numbers of subjects and risk estimates with wide confidence intervals have been noted to avoid undue emphasis on these data, and they require more detailed investigation in future studies. Biologic plausibility, confounding, and effect modification also were considered when exposure effects were evaluated.
Lymphomagenesls
The findings from our study implicate environmental factors that may influence early stages of lymphomagenesis by stimulating the immune system. Antigendriven B cells that accumulate to form lymphoma may be suppressed by immunologic stresses such as exposure to an increased number of sexual partners and to certain medications. Conversely, a history of allergies provides evidence for the persistent capacity for B-cell differentiation and therefore a decreased accumulation of B cells. The decreased risk for non-Hodgkin's lymphoma with use of NSAEDs and cholesterol-lowering drugs is consistent with a macrophage inflammatory role in B-cell proliferation and implicates the earliest stages of immune activation in lymphomagenesis. These data provide further support for immunologic activation in lymphomagenesis and, if confirmed in other work, suggest that NSAIDs and perhaps cholesterol-lowering drugs may be useful in reducing the risk for non-Hodgkin's lymphoma. Also, if B-cell lymphomas arise from a population of lymphocytes active in an immunologic response to an antigen, then sexual practices, drug use, and other behavior patterns associated with mild immunosuppression, as described in our study, may decrease the likelihood of developing non-Hodgkin's lymphoma.
The results presented here are consistent with our results regarding HIV-negative homosexual men (6) and provide additional support for the role of immune system B-cell function in lymphomagenesis. The finding of a decreased risk for cancer associated with allergy-related conditions is not unique to this study, and we have shown a consistently decreased risk for non-Hodgkin's lymphoma associated with exposures that can result in mild immunosuppression. Large studies designed to gather detailed laboratory, clinical, and epidemiologic data will best be able to elucidate the joint processes of immune function and development of non-Hodgkin's lymphoma and thereby support or refute the provocative associations reported here.
